Dysbindin Domain-Containing 1 in Prostate Cancer: New Insights into Bioinformatic Validation of Molecular and Immunological Features.
DBNDD1 gene expression
E2F
GSK-3β
bioinformatic investigation
cell cycle
dysbindin protein family genes
immunology
microtubule cytoskeleton
prostate cancer
tumor-infiltrating immune cell
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
25 Jul 2023
25 Jul 2023
Historique:
received:
14
06
2023
revised:
17
07
2023
accepted:
19
07
2023
medline:
12
8
2023
pubmed:
12
8
2023
entrez:
12
8
2023
Statut:
epublish
Résumé
Prostate cancer (PCa) is one of the most prevalent cancers in men, yet its pathogenic pathways remain poorly understood. Transcriptomics and high-throughput sequencing can help uncover cancer diagnostic targets and understand biological circuits. Using prostate adenocarcinoma (PRAD) datasets of various web-based applications (GEPIA, UALCAN, cBioPortal, SR Plot, hTFtarget, Genome Browser, and MetaCore), we found that upregulated dysbindin domain-containing 1 (
Identifiants
pubmed: 37569304
pii: ijms241511930
doi: 10.3390/ijms241511930
pmc: PMC10418609
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : 1. National Science and Technology Council, Taiwan 2. National Health Research Institutes, Taiwan 3. TMU Research Center of Cancer Translational Medicine
ID : 1. MOST109-2326-B-038-001-MY3 2. MOST111-2628-B-038-016-MY3
Références
J Microbiol Immunol Infect. 2021 Oct;54(5):845-857
pubmed: 34176764
Biomedicines. 2021 Nov 30;9(12):
pubmed: 34944621
Nucleic Acids Res. 2000 Jan 1;28(1):27-30
pubmed: 10592173
Prostate Cancer Prostatic Dis. 2014 Sep;17(3):220-6
pubmed: 24796290
Nat Rev Mol Cell Biol. 2001 Oct;2(10):769-76
pubmed: 11584304
Nature. 2018 Jul;559(7714):363-369
pubmed: 29950727
Adv Immunol. 2007;96:179-204
pubmed: 17981207
J Mol Cell Biol. 2017 Dec 1;9(6):504-515
pubmed: 29040676
Front Pharmacol. 2021 Sep 23;12:738235
pubmed: 34630112
Cancer Cell. 2005 May;7(5):411-23
pubmed: 15894262
Front Oncol. 2020 Oct 29;10:517637
pubmed: 33194581
Front Immunol. 2020 Jul 30;11:1680
pubmed: 32849585
Psychooncology. 2013 Oct;22(10):2169-76
pubmed: 23483679
Nat Med. 2016 Apr;22(4):369-78
pubmed: 26928463
Nucleic Acids Res. 2017 Jul 3;45(W1):W98-W102
pubmed: 28407145
Eur J Pharmacol. 2020 Jun 15;877:173090
pubmed: 32234529
Nucleic Acids Res. 2014 Jan;42(Database issue):D472-7
pubmed: 24243840
Sci Rep. 2019 Nov 8;9(1):16359
pubmed: 31704974
Cell. 1997 Feb 7;88(3):323-31
pubmed: 9039259
J Pers Med. 2021 Oct 26;11(11):
pubmed: 34834441
Cancer Res. 2017 Nov 1;77(21):e108-e110
pubmed: 29092952
Urol Oncol. 2015 Nov;33(11):456-63
pubmed: 26051358
Mod Pathol. 2018 Jan;31(S1):S110-121
pubmed: 29297495
Am J Clin Exp Urol. 2022 Aug 15;10(4):210-233
pubmed: 36051616
Nucleic Acids Res. 2012 Jan;40(Database issue):D1301-7
pubmed: 22096230
BMC Cancer. 2021 Mar 16;21(1):286
pubmed: 33726701
Nat Rev Cancer. 2001 Nov;1(2):109-17
pubmed: 11905802
BMC Genomics. 2015 Oct 28;16:873
pubmed: 26510534
Schizophr Res. 2003 Apr 1;60(2-3):167-72
pubmed: 12591580
Nat Commun. 2023 Mar 30;14(1):1787
pubmed: 36997534
Nat Cancer. 2021 Aug;2(8):803-818
pubmed: 35122025
Science. 1989 Nov 3;246(4930):629-34
pubmed: 2683079
Cell Death Dis. 2018 Oct 11;9(10):1041
pubmed: 30310055
Prostate. 2012 May 1;72(6):649-60
pubmed: 21837779
J Cancer. 2020 Feb 21;11(10):2821-2829
pubmed: 32226500
J Immunother Cancer. 2022 Mar;10(3):
pubmed: 35296557
Sci Rep. 2022 Jan 7;12(1):211
pubmed: 34997064
Cell. 2018 Apr 5;173(2):305-320.e10
pubmed: 29625049
Gene. 2019 Aug 20;710:333-340
pubmed: 31202904
Front Oncol. 2022 Aug 11;12:958756
pubmed: 36033455
Cancers (Basel). 2021 Sep 29;13(19):
pubmed: 34638387
Anticancer Res. 2009 Jun;29(6):2077-81
pubmed: 19528467
Front Surg. 2022 Mar 17;9:856446
pubmed: 35372462
Cancer Lett. 2022 Jan 28;525:9-21
pubmed: 34715253
Int J Mol Sci. 2021 Mar 05;22(5):
pubmed: 33807717
Nat Genet. 2000 May;25(1):25-9
pubmed: 10802651
Nat Biotechnol. 2020 Jun;38(6):675-678
pubmed: 32444850
Aging (Albany NY). 2021 Jul 30;13(14):17970
pubmed: 34329194
Mol Psychiatry. 2010 Oct;15(10):969
pubmed: 20861847
Cancer Lett. 2020 May 1;477:107-121
pubmed: 32120026
Aging (Albany NY). 2022 Oct 30;14(20):8498-8567
pubmed: 36315446
Neoplasia. 2017 Aug;19(8):649-658
pubmed: 28732212
EMBO Mol Med. 2014 May 01;6(5):651-61
pubmed: 24737870
Int J Oncol. 2016 Apr;48(4):1650-8
pubmed: 26891801
Genomics Proteomics Bioinformatics. 2020 Apr;18(2):120-128
pubmed: 32858223
Nucleic Acids Res. 2013 Jan;41(Database issue):D991-5
pubmed: 23193258
Methods Mol Biol. 2007;395:17-34
pubmed: 17993665
Cells. 2020 Jul 08;9(7):
pubmed: 32650578
Oncol Rep. 2020 Sep;44(3):849-862
pubmed: 32582990
Schizophr Bull. 2005 Oct;31(4):800-5
pubmed: 16166606
Nucleic Acids Res. 2022 Jul 5;50(W1):W367-W374
pubmed: 35609980
Cancer Lett. 2016 May 28;375(1):152-161
pubmed: 26968249
J Cell Physiol. 2016 Nov;231(11):2482-92
pubmed: 26919443
Am J Hum Genet. 2006 Nov;79(5):903-9
pubmed: 17033966
Diagnostics (Basel). 2019 Dec 11;9(4):
pubmed: 31835700
Oncogene. 2023 Mar;42(12):926-937
pubmed: 36725887
J Cell Physiol. 2020 Nov;235(11):8472-8485
pubmed: 32329523
Molecules. 2022 Sep 05;27(17):
pubmed: 36080493
Infect Genet Evol. 2020 Nov;85:104438
pubmed: 32615317
Nature. 2020 Mar;579(7800):567-574
pubmed: 32214244
Clin Cancer Res. 2009 Sep 15;15(18):5794-802
pubmed: 19737960
Nature. 2022 Sep;609(7927):S42-S44
pubmed: 36104410
Cancer Cell. 2005 Nov;8(5):393-406
pubmed: 16286247
J Immunol Res. 2022 Sep 1;2022:3883822
pubmed: 36093436
Cancers (Basel). 2021 Apr 18;13(8):
pubmed: 33919517
Nat Commun. 2023 Mar 22;14(1):1449
pubmed: 36949101
CA Cancer J Clin. 2023 Jan;73(1):17-48
pubmed: 36633525
J Clin Invest. 2018 Jan 2;128(1):341-358
pubmed: 29202480
Aging (Albany NY). 2021 Nov 28;13(22):24882-24913
pubmed: 34839279
Nature. 2010 Mar 11;464(7286):302-5
pubmed: 20220849
Am J Cancer Res. 2020 Jan 01;10(1):95-113
pubmed: 32064155
Proc Natl Acad Sci U S A. 2019 Oct 22;116(43):21704-21714
pubmed: 31591235
Pathology. 2019 Aug;51(5):463-473
pubmed: 31279442
Cancer Res. 2022 Jan 15;82(2):221-234
pubmed: 34625422
Prostate Cancer Prostatic Dis. 2009;12(3):233-40
pubmed: 19488067
J Exp Clin Cancer Res. 2023 Jan 14;42(1):22
pubmed: 36639681
Cancers (Basel). 2020 Jan 18;12(1):
pubmed: 31963677
Am J Cancer Res. 2021 Apr 15;11(4):1012-1030
pubmed: 33948343
Cells. 2020 Apr 28;9(5):
pubmed: 32354165
Int J Mol Sci. 2017 Sep 22;18(10):
pubmed: 28937620
Endocr Relat Cancer. 2020 Feb;27(2):R35-R50
pubmed: 31804971
EMBO J. 2004 Oct 27;23(21):4202-10
pubmed: 15470505
Cancer Inform. 2019 Mar 13;18:1176935119835522
pubmed: 30890858
Int J Mol Sci. 2022 Jan 12;23(2):
pubmed: 35054979
Cancers (Basel). 2023 Feb 01;15(3):
pubmed: 36765877